CV Risk
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects (NCT00648284) | GlaxoSmithKline | 2004-03-01 |
Track CV Risk automatically
Every clearance here is in the API, with alerts when new ones post.